Skip to main navigation

Home
Synthetic Biology
- The History of Synthetic Biology
Living Medicines
- Designing Synthetic Biotics
Pipeline + Programs
- Partner with Us
Clinical Trials
Our People
Investors + Media

explore the
possibilities

Synlogic Therapeutics

Investor Relations

IR menu

Overview
News
News Releases In the News
Events & Presentations
Events Presentations
Publications
Stock Information
Stock Quote & Chart Analyst Coverage
Corporate Governance
Governance Highlights Leadership Board of Directors Committee Composition Board Diversity Matrix
Financials
SEC Filings Quarterly Results
Investor Resources
FAQs Contact IR Email Alerts RSS Feeds

In the News

Home
Synthetic Biology
- The History of Synthetic Biology
Living Medicines
- Designing Synthetic Biotics
Pipeline + Programs
- Partner with Us
Clinical Trials
Our People
Investors + Media

Source

Life Sci VC

JPM and Other Rituals

January 18, 2023

JPM and Other Rituals

Source

CheckRare

PKU Treatment: Medical Foods vs Kuvan vs Palynziq

January 17, 2023

PKU Treatment: Medical Foods vs Kuvan vs Palynziq

Source

CheckRare

Mechanism of Action of SYNB1353 to Treat Homocystinuria

January 10, 2023

Mechanism of Action of SYNB1353 to Treat Homocystinuria

Source

CheckRare

What is Homocystinuria (HCU)?

January 9, 2023

What is Homocystinuria (HCU)?

Source

WBUR Radio Boston

How local business leaders are thinking about leadership in 2023

January 3, 2023

How local business leaders are thinking about leadership in 2023

Source

CheckRare

How Homocystinuria Is Currently Treated

December 15, 2022

How Homocystinuria Is Currently Treated

Source

BioProcess International

Using Synthetic Biology To Develop Novel Biotherapeutics

December 12, 2022

Using Synthetic Biology To Develop Novel Biotherapeutics

Source

Endpoints News

FDA remains silent on orphan drug exclusivity after last year's court loss

December 1, 2022

FDA remains silent on orphan drug exclusivity after last year's court loss

Source

Nature

Seeking therapeutic opportunities amid the complexity of the microbiome

November 24, 2022

Seeking therapeutic opportunities amid the complexity of the microbiome

Source

Biocentury

Phenylketonuria pipeline breaks into new modalities

November 23, 2022

Phenylketonuria pipeline breaks into new modalities 478.5 KB

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Investor Resources

Contact IR
Investor FAQs
RSS Feeds

Investor Email Alerts

Email

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

Twitter
LinkedIn
Youtube
Facebook
Instagram

Privacy and Terms

© 2023 Synlogic
Privacy Policy